Not only is daylight photodynamic therapy as effective as conventional photodynamic therapy (using blue light) for the treatment of actinic keratosis but it is less painful, a novel study finds.
The purported benefits of imiquimod for the treatment of basal cell carcinoma are disputed in a critical review that finds numerous study flaws.
From 2013 to 2016, there was a large decrease of 17.9 percent in melanoma mortality.
A vismodegib regimen that includes a weekend drug holiday showed similar responses to treatment for patients with advanced basal cell carcinoma and basal cell nevus syndrome and provided a more tolerable adverse effect profile.
BRAF V600E mutation may indicate a reduced risk for relapse and/or metastasis in patients with melanoma.
There is a decreased risk for melanoma diagnosis among bereaved individuals but increased mortality associated with melanoma compared with nonbereaved individuals.
The FDA has accepted for filing the New Drug Application for tirbanibulin ointment (formerly known as KX2-391 or KX-01 ointment; Athenex) for the treatment of actinic keratosis (AK).
Physicians may be reassured, when prescribing methotrexate to their patients with psoriasis, as no association between methotrexate exposure and risk for cutaneous malignant melanoma was noted in a sizeable study.
The percentage of cases of cutaneous melanoma and age-standardized incidence rates attributable to ultraviolet radiation vary across states.
The researchers found that compared with heterosexual men, gay and bisexual men had significantly higher adjusted odds ratios of skin cancer prevalence.